Plastic syringes are Class IA medical devices which are used frequently for the administration of drugs parenterally. Syringes and their materials have to fulfil the tests like transparency, water vapor permeability, leakage and cytotoxicity. These tests are indicated in pharmacopoeias and they are applied for the understanding whether is suitable to standard. Also they obey to some requirements such as electrical properties, sterility, chemical resistance and extractables/ leachables. These requirements are indicated in standards. In this article, firstly the requirements and tests are mentioned. Afterwards, sterilization of plastic syringes with ethylene oxide or radiation and the effects of radiation sterilization on the plastic syringe materials are explained. Finally, several studies done on the possible interaction between plastic materials of syringes and some chemical solutions have been summarized. Tıbbi Cihaz Olarak Enjektörler ÖZET Plastik şırıngalar sıklıkla ilaçları parenteral yoldan uygulamak için kullanılan Sınıf IA tıbbi cihazlardır. Şırıngalar ve şırıngaların yapıldıkları malzemeler şeffaflık, su buharı geçirgenliği, sızdırma ve sitotoksisite gibi testleri geçmek zorundadır. Bu testler şırıngaların ve malzemelerin standartlara uyup uymadığını saptamak için yapılır ve farmakopelerde belirtilmiştir. Ayrıca şırıngalar elektriksel özellikler, sterilite, kimyasal direnç ve ekstre edilebilir maddeler/ ağartıcılar bakımından bazı gerekliliklere uymak zorundadırlar. Bu gereklilikler standartlarda belirtilmiştir. Bu makalede, ilk olarak bu gereklilikler ve testlerden bahsedilmiştir. Ardından plastik şırıngaların etilen oksit veya radyasyon ile sterilizasyonu ve plastik şırınga malzemeleri üzerinde radyasyonla sterilizasyonun etkileri açıklanmıştır. Son olarak plastik şırınga materyali ve bazı kimyasal çözeltiler arasında oluşabilecek etkileşimle ilgili yapılan çalışmalar özetlenmiştir.

Figure: 1. Syringe and Pieces (Syringes).

Figures - uploaded by Merve Karpuz

Author content

All figure content in this area was uploaded by Merve Karpuz

Content may be subject to copyright.

ResearchGate Logo

Discover the world's research

  • 20+ million members
  • 135+ million publications
  • 700k+ research projects

Join for free

FABAD J. Pharm. Sci., 41, 27-37, 2016

Syringes As Medical Devices

Merve KARPUZ*,**, A. Yekta ÖZER

REVIEW ARTICLES

27

* Hacettepe University, Faculty of Pharmacy, Department of Radiopharmacy, 06100, Sıhhiye, Ankara-Turkey.

** İzmir Katip Çelebi University, Faculty of Pharmacy, Department of Radiopharmacy, 35620, Çiğli, İzmir-Turkey.

°Corresponding Author:

Phone: +90 312 305 21 96

Fax: +90 312 311 47 77

E-mail : yktzer@yahoo.com

Syrnges As Medcal Devces

SUMMARY

Plastc syrnges are Class IA medcal devces whch are used

frequently for the admnstraton of drugs parenterally. Syrnges and

ther materals have to fulfl the tests lke transparency, water vapor

permeablty, leakage and cytotoxcty. ese tests are ndcated n

pharmacopoeas and they are appled for the understandng whether

s sutable to standard. Also they obey to some requrements such as

electrcal propertes, sterlty, chemcal resstance and extractables/

leachables. ese requrements are ndcated n standards. In ths

artcle, frstly the requrements and tests are mentoned. Afterwards,

sterlzaton of plastc syrnges wth ethylene oxde or radaton and

the eects of radaton sterlzaton on the plastc syrnge materals

are explaned. Fnally, several studes done on the possble nteracton

between plastc materals of syrnges and some chemcal solutons

have been summarzed.

Key Words: Syrnges, Sterlzaton, Radaton sterlzaton,

Radaton eects on plastc materal, Chemcal nteracton n plastc

syrnges.

Received: 12.12.2016

Revised: 20.01.2017

Accepted: 23.01.2017

Tıbb Chaz Olarak Enjektörler

ÖZET

Plastk şırıngalar sıklıkla laçları parenteral yoldan uygulamak çn

kullanılan Sınıf IA tıbb chazlardır. Şırıngalar ve şırıngaların

yapıldıkları malzemeler şeaık, su buharı geçrgenlğ, sızdırma ve

stotoksste gb testler geçmek zorundadır. Bu testler şırıngaların

ve malzemelern standartlara uyup uymadığını saptamak çn

yapılır ve farmakopelerde belrtlmştr. Ayrıca şırıngalar elektrksel

özellkler, sterlte, kmyasal drenç ve ekstre edleblr maddeler/

ağartıcılar bakımından bazı gerekllklere uymak zorundadırlar.

Bu gerekllkler standartlarda belrtlmştr. Bu makalede, lk

olarak bu gerekllkler ve testlerden bahsedlmştr. Ardından plastk

şırıngaların etlen okst veya radyasyon le sterlzasyonu ve plastk

şırınga malzemeler üzernde radyasyonla sterlzasyonun etkler

açıklanmıştır. Son olarak plastk şırınga materyal ve bazı kmyasal

çözeltler arasında oluşablecek etkleşmle lgl yapılan çalışmalar

özetlenmştr.

Anahtar kelimeler: Şırıngalar, Sterilizasyon, Radyasyonla

Sterilizasyon, Plastik materyaller üzerine radyasyonun etkisi,

Plastik şırınga materyalindeki kimyasal etkileşmeler.

28

Karpuz, Özer

INTRODUCTION

ere are four major systemic routes for the

administration of drugs to the body: enteral,

parenteral, transdermal and inhalation. Parenteral

routes have some advantages such as quick drug

eect, 100 % bioavailability, protecting drugs from the

eect of gastrointestinal system and preventing the

formation of inactive drugs before drug eects occur

(Oktay & Kayaalp, 2012). Plastic syringes are the most

commonly used instruments for the administration

of drugs parenterally and they are medical devices

designated as Class IA.

e first study, which is about administration of

drugs into the body through the skin, was made by

Magendie in 1809. For this purpose, he administered

strychnine into a dog by using a wood coated thorn.

Aer that, Lafargue introduced morphine by using

a lancet. Rynd invented a dripping needle in 1844.

Finally in 1853 by Wood, first real syringe was

invented for the purpose of treating birthmarks and

a few years later aer this date, he added a barrel and

a better needle to this invention (How Products Are

Made Volume 3 Syringe).

TYPES and CLASSIFICATION of SYRINGES

Syringes are named according to the volume

and the usage purpose and they are classified into

disposable syringes and non-disposable syringes. In

Table 1, types of syringes and the commercial samples

are summarized. Disposable syringes are sterile,

packed, ready for use, non-toxic, non-pyrogenic and

have lower risk in transmitting the diseases such as

AIDS or Hepatitis B than non-disposable syringes.

So they are preferred mostly. Non-disposable

syringes are generally made of heat-resistant glass

such as borosilicate and they are not used very oen

(Pharmacology chapter).

ere are 2 type of syringes according to intended

use; oral and hypodermic.

Oral syringes are used eiciently in the

administration of drugs by oral or enteral route

and the preparation of drugs which have very small

volume (Grissinger, 2013).

Hypodermic syringes are calibrated by cubic

centimeter (cc), mililitre (ml) or unit. Small volume

syringes, which have 1, 2, 2.5, 3 ml volumes, are used

in the administration of the intramuscular (i.m.)

or subcutan (s.c.) injections. Syringes which have

larger volumes such as 5, 6, 10, 12 ml, are used in the

blood draw from patients or in the preparation of the

drugs for intravenous (i.v.) injections and syringes,

which have larger volume than 20 ml, are used in the

injections of larger volume sterile solutions (Chapter

7 Syringes).

In accordance with the special intented use, there

are 3 types of syringes: Insulin, Tuberculin and Pre-

filled Syringes.

Insulin syringes are used in the injection of

insulin hormone, which takes place in the treatment

of Insulin Dependent Diabetes Mellitus and they are

calibrated by unit (Chapter 7 Syringes).

Other syringe type is Tuberculin syringes which

are used in the diagnosis of tuberculosis. eir volumes

are 1 ml and on the syringe barrel there are 100 lines

which show 0.01 ml each. is type of syringes are

used for intradermal (i.d.) injection of very small

volume drugs which are used in tubeculosis and

allergy tests. Also, they are preferred for i.m. injection

of the drugs which have small volumes lower than 1

ml (Chapter 7 Syringes).

When types of syringes are mentioned, pre-filled

syringes mustn't be forgotten. Pre-filled syringes ,

which are used for the administration of the various

liquid drugs (such as insulin or vaccines), are single

dose cartridges that have fixed needles on it (Dunne &

Whitaker, 2016). ere are a lot of advantages of pre-

filled syringes over traditional vials and ampoules for

the patients and health workers (Yoshino et al. ,2014;

Makwana et al.,2011):

 Minimizing of the drug waste,

 Extra time for the drug shelf life,

 Being eective, safe and useful,

 Providing of the precise dose drug

administration rapidly,

 Minimizing of dose mistakes and risk of

biological contamination,

 Allowing the patients administration of

drugs by themselves out of the hospital.

Pre-filled insulin syringes especially are

recommended for the patients, who use insulin in

diabetes treatment, because of adsorption eect of

plastic syringes (Dunne & Whitaker, 2016). In the

production of this type of syringes, Class I borosilicate

glass for syringe barrel; stainless steel or elastomer

for needle; elastomer for plunger and cap and plastic

materials for the other pieces of the syringe are

used, respectively. e plastic materials used in the

production are cyclo olefin polymers (COP) or cyclic

olefin copolymers (COC). In the sterilization of these

types of syringes, autoclave or ionized radiation can

be used but the main sterilization method is gamma

radiation sterilization (Makwana et al., 2011).

29

FABAD J. Pharm. Sci., 41, 27-37, 2016

Table: 1. Types of Syringes

According to Material 1. Plastic Syringes

1.1. Polypropylene (Hayat®, Sigma-Aldrich®)

1.2. Polyethylene (Sigma-Aldrich®, Norm-Ject ®)

2. Glass Syringes (Sanitex ®)

According to Administration Route 1. Hypodermic Syringes (Hayat®)

2. Oral syringes (BD UniVia™)

According to Special Intended Use 1. Tuberculin Syringes (MonojectTM)

2. Insulin Syringes (GNP®)

3. Pre-filled Syringes (Mırcera®)

MATERIALS of SYRINGES

Although a lot of syringes have been designed until

now, all of the syringe types basically have the same

pieces like plunger, barrel, needle and cap as shown in

Figure 1 (How Products Are Made Volume 3 Syringe).

Figure: 1. Syringe and Pieces (Syringes).

If the syringe needle is made of stainless steel, it

is hypodermic type needle. ere are some methods

for measuring the diameter of the syringe needle such

as French Catheter Gauge, Metric Sizes in Milimeters,

Stubs Wire Gauge. Among them Stubs Wire Gauge

method is the most frequently used for medical

catheters and equipment in worldwide. In accordance

with this system, if the aperture of pinhole is 0.134

inch it is called 10 gauge and is 0.035 inch for the 20

gauge (Kucklick, 2006).

Syringe plunger, barrel and cap are made of

polypropylene (PP) or polyethylene (PE) plastic

materials. ese materials must be at medical grade

because of their medical use. For this purpose, some

essential tests are applied to the plastic materials and

the materials are characterized by their composition,

mechanical- thermal and electrical properties,

sterility, chemical resistance and extractables/

leachables, biocompatibility, hemocompatibility

and stability. Among them mechanical thermal and

electrical properties, sterility, chemical resistance

and extractables/ leachables are the most important

properties of the produced syringes. Biocompatibility

and hemocompatibility are not very important

because of no contact in between the syringe barrels

and skin or blood (Sastri, 2014).

Some test methods, like combustion, extractable

substances, fine particles, transparency, water vapor

permeability, leakage and cytotoxicity, take place in

pharmacopeias. Depending on the results of these test

methods, the requirements for PP and PE containers,

which are used for aqueous injection, are indicated.

According to Japanese Pharmacopeia (2011a):

• Transparency : When it is tested as defined

at pharmacopoeia, material transmittance is not less

than 55%. At sensory test, turbidity is not more than

20% in the water loaded container and also being

turbid is not more than 80% in the suspension loaded

container.

• Appearance: Materials must not include

cracks or bubbles.

• Water Vapor Permeability: Depending on the

results of tests which are defined pharmacopoeial test

methods, the loss of mass is not more than 0.2%.

• Heavy Metals: e turbidity of the test solution

must not greater than that of the control solution.

• Cadmium: According to the results of applied

test, the absorbance of the test solution must not be

dierent from control's absorbance.

• Residue on Ignition: is must not be more

than 0.1% in 5 gram.

• Foaming Test: e foam must disappear in 3

minutes.

• pH: e pH dierence in between the blank

and test solution is not more than 1.5.

• UV Spectrum: In 220-240 nm it must not be

more than 0.08 and in 241-350 nm it must not be

more than 0.05.

• Residue on Evaporation: It must not be more

than 1.0 mg.

• Half Maximal Inhibitory Concentration

(IC50 ): It must not be more than 90%.

According to European Pharmacopeia (2008a):

• Appearance of S Solution: S solution, which is

prepared with suicient number of syringes, must be

clear and colourless.

• Acidity or alkalinity: When 0.1 ml

30

Karpuz, Özer

bromothymol blue added to 20 ml S solution is

titrated with 0.01 M HCl or NaOH, the amount of acid

or alcali must not be used more than 0.3 ml.

• Absorbance: In between 230-306 nm, it must

not be more than 0.2.

• Reducing Agents: When the S solution and

blank solution (fitting to phar macopeial requirements)

are titrated with 0.01 M sodium thiosulfate solution,

the dierence between the volumes should not be

more than 1.5 ml.

PRODUCTION of SYRINGES

Along the process of syringe production, some

tests are applied to syringes in order to understand

whether the requirements were provided or not. is

tests and requirements are indicated in national and

international standards which are summarized in

Table: 2.

Table: 2. National and International Standards for Syringes

TS EN ISO 8537 Sterile single-use syringes, with or without needle, for insulin

TS EN ISO 21533/AC Dentistry - Reusable cartridge syringes intended for intraligamentary injections

TS EN ISO 7886-1 Syringes-Hypodermic-Single use, sterile Part1: Syringes-Manual

TS EN ISO 7886-2 Sterile hypodermic syringes for single use - Part 2: Syringes for use with power-driven syringe

pump

TS EN ISO 7886-3 Sterile hypodermic syringes for single use - Part 3: Auto-disable syringes for fixed-dose

immunization

TS EN ISO 7886-4 Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention feature

TS ISO 11040-3 Prefilled syringes - Part 3: Seals for dental local anesthetic cartridges

TS 3592 Needles for Syringes

TS 4021 Ear Syringe- Metal

TS 5031 Insulin Syringes-Reusable

TS 5462 Tuberculin Syringes

TS EN ISO 9997 Dental Cartridge Syringes

According to TS EN ISO 7886-1 (1998), TS EN

ISO 7886-2 (2006), TS EN ISO 7886-4 (2007):



When the syringe pieces (plunger, barrel, needle

and cap) are investigated in between 300 and 700 lux-

light without magnifying glass, the syringe surfaces

which are directly contact with injection liquids, must

not include particles or impurities.



For the evaluation of pH value and amount

of extractable metals, at least 3 syringes are filled to

nominal capacity line with distilled water which is

suitable for the third degree in TS ISO 3696 and they

are kept throughout 8 hours (0/+15 min.) at 37 (0/+3)

oC. In order to evaluate the needle of the syringe

pH, 25 needles are immersed in distilled water and

kept throughout 60±2 minutes. e content was

decanted to a borosilicate glass and is compared with

control solutions which are prepared from freshly

distilled water. When the pH values of the content are

compared, it must not be higher 1 unit than control

solution. Total amount of lead, tin, zinc and iron

must not be higher than 5 mg.L-1 and also amount of

cadmium must be less than 0.1 mg.L-1.



If any lubricant is used for the inner surfaces of

syringe barrels and needles, particle of lubricant, which

is in droplet form, must not be seen at visual inspection.

For three pieces syringes, polydimethylsiloxane must

be used as lubricant and its amount must not be higher

than 0.25 mg. Also, in two pieces syringes amide of

erucic and oleic acids must be used as lubricant and

the amount of lubricant must not exceed 6% (m.m-1 )

the mass of the cylinder.



e pinpoint of syringe must be sharp and

smooth.



Syringe has to have identical scale which is

calibrated in one or more interval and volume of

syringe must be shown at syringe barrel.



e length of syringe barrel is suitable to

provide maximum usable capacity which must be at

least 10 % more than the nominal capacity.



Syringes must have finger grips which prevent

rotation more than 180 degrees when syringes are

placed horizontally at at which is angled 10 degree

with horizontal plane. In addition, finger grips must be

in appropriate shape, measure and resistance and they

must not have sharp edge or bulge.



When the barrel of syringe is held in one hand,

the plunger can be pushed by the same hand. For this

purpose, syringe nozzle is connected to reference

steel cone and syringe fills with water. While negative

pressure is applied from nozzle, possible disconnection

between piston and the body of piston is checked.

31

FABAD J. Pharm. Sci., 41, 27-37, 2016



When the syringe filled with water and hold

vertically, body of piston must not move because of

its weight. e force for the movement of piston body

and to fill water to the syringe or to discharge the

water from the syringe is determined by mechanical

experiment machine.



Fiducial line must be contacted with the inner

surface of barrel.



According to TS 3521-1 EN20594-1, syringe

nozzle must be compatible with conical connection

and nozzle lumen must not be less than 1.2 mm.



In order to understand the void volume in

syringe, the dry syringe is weighted and filled with

water, discharged, syringe's outer surface is dried and

it is reweighted. e void volume is calculated from

the weight of the residual water. is finding is in

accordance with the value mentioned in the standards.



To test the air and liquid leakage, the syringe

is filled with water, syringe nozzle is closed, a force is

applied to piston and possible amount of leakage is

checked.



Flow properties of syringe is determined by

using reference syringe driver. Depending on the

results of this method, the time which is necessary for

reaching at least 95% level, fixed ow speed is set by

the movement of piston rod's push button must not

exceed 10 minutes. Total percentage of error of ow/

set distribution speed, must not be higher than ±2%.



e force which is necessary for the drainage of

water is determined by a mechanical machine. At the

end of these experiments, the determined force must

appropriate to the designated values in standards.



Packaging and labeling which are the last steps

of the syringe production, should be appropriate to the

designated values in standards.

STERILIZATION of SYRINGES

According to the old definition, sterilization is

the elimination of all the alive organism, bacteria and

fungi spores and saving the contents of products from

microorganisms, absolutely.

Recently, sterilization is defined as the presence

probability of viable microorganism in one million

product.

eoretically, in order to designate a medical device

as sterile, the probability level shou ld be lower than one

to a million (Perçin, 2014). Sterility Assurance Level

(SAL) is the term used for expression of reaching of

the sterility to the desired level. In other words, SAL is

a term which can be defined as probability of presence

non-sterile products or survival of microorganisms in

the samples. For medical devices SAL level is very low

like 10-6 (Turker, 2009a.; Sterility Assurance Level).

Among the main sterilization methods, there are

several sterilization methods like sterilization with

dry air at oven, sterilization with pressurized steam

in autoclave at 121oC, UV radiation sterilization,

ethylene oxide (EO) sterilization, ionized radiation

sterilization which uses gamma rays or electron beam

(e-beam) and sterilization in aseptic conditions by

using membrane filters which have pores in 0.22 µm

diameter (Silindir & Ozer, 2009; Moraes et al., 2014).

Syringes have to be sterile because of their use in

the administration of sterile and apyrogenic drugs by

parenteral route. Sterilization of products is possible

in the terminal packages. Microbial death/ bioburden

control are evaluated by this method and has the lowest

risk. Because of these reasons, terminal sterilization

method is recommended (Japenese Pharmacopoeia,

2011b ).

Among the sterilization methods, there are two

methods used for the sterilization of syringes. One

of them is EO sterilization which has been used

since the 1950s. is method is especially suitable for

heat-sensitive and moisture-sensitive materials. Pure

EO gas is ammable and explosive, also according

to Environmental Protection Agency (EPA) toxic

and carcinogenic gas. So EO gas is diluted with

some agents like hydrochlorouorocarbon (HCFC)

and carbon dioxide. ere are some disadvantages

of this method; for instance it is complex because

of depending on some critical parameters such as

temperature (30-65oC), amount of relative humidity

present (30-99%), EO concentration (250-1500

mg.ml-1 ), overall exposure time (1-30 hours), type of

microorganisms, product and load density, and gas

permeability factors. In addition, due to the formation

of EO decomposition products aer sterilization

process it requires aeration (Sastri, 2014; Silindir &

Ozer, 2009; United States Pharmacopeia, 2009).

Other sterilization method is ionized radiation

sterilization which uses gamma rays or e-beam. In

order to apply this sterilization method in pratice, the

first national dra law has been published in 1965.

Nowadays, there are Food and Drug Administration

(FDA) in USA and Department of Health and Social

Services (DHSS) in UK for checking the suitability

of facilities with laws and regulations. In addition,

Occupational Safety and Health Administration

(OSHA) and Environmental Protection Agency (EPA),

which was established in 1997 within the framework

US Clean Air Act, specify sine qua non about the

safety of personnel and the protection of environment.

Before mentioned authorities and International

Atomic Energy Agency (IAEA) determine the high

standards on international basis; among these:

32

Karpuz, Özer

providing the safety running of radiation sources

and application of appropriate radiation doses to the

products steadily, providing radiation sterilization use

in industry (Fairand, 2002).

e radiation energy is supplied by accelerators,

which provides 10 MeV power of e-beam or 60 Co

radionuclide which emits 1.33 MeV power of gamma

rays. Sterilization with e-beam has some advantages

(Silindir & Ozer, 2009; Fintzou et al., 2007a, 2007b;

Haji-Saeida, 2007):

(a) Safe and reliable method,

(b) Ease of control,

(c) High dose rate,

(d) Insignificant increasing of temperature.

On the other hand, penetration of gamma rays is

higher than e-beam, so this makes that gamma rays is

more popular than e-beam. In addition, in the e-beam

irradiation the applied dose rate is higher but the time

is shorter than at gamma irradiation. For instance,

there is an equality between 15 kW e-beam and 1 MCi

gamma sources. e radiation dose for sterilization is

changing in between 25 and 40 kGy. e application

dose must be identified before the sterilization of

syringes in order to show relationship between dose

range and remaining of non-sterile items. Also, by the

identification of dose rate, application of unsuitable

radiation dose which is lower than eective sterilization

dose, is prevented (Fintzou et al., 2007a, 2007b;

Haji-Saeida et al. , 2007; Ley et al., 1972). In order to

reach the desired SAL level, suitable radiation dose is

determined by using Bacillus Pumilus spores which

are the most resistant microorganism to irradiation.

For this purpose, the samples obtained from products

produced properly according to Good Manufacturing

Practice (GMP) conditions, are contaminated by

Bacillus Pumilus spores and in this way microbial

bioburden is created. Microbal bioburden is the

number of alive microorganisms on the products

which will be sterilized, and is determined in fours

steps (Berk, 2002a, 2002b):

I. Removal of microorganisms from the

products,

II. Incubating of these microorganisms in the

suitable medium,

III. End of the incubation period, counting of

the microorganisms colony growth,

IV. Application of microbial bioburden

correction factor.

e product, it's microbial bioburden which is

known, is irradiated by specific radiation dose (such

as 5, 10, 25, 50 kGy). e remaining microorganisms

on the samples, aer irradiation is counted and

plotted to show the relation between radiation dose

and microbial death rate. According to the graphs, the

optimal irradiation dose is obtained showing this dose

appropriate to SAL 10-6 (Berk, 2002a).

In the radiation sterilization method, 25 kGy

irradiation dose is accepted for providing SAL at 10-

6. If there is no information about the number and

resistance of the microbial bioburden, the product has

to be irradiated with 25 kGy it means (Berk, 2002b).

Aer the sterilization of the syringes, some tests

are performed on solutions which are prepared from

the sterilized syringes, in order to check the sterility.

One of these tests is in vitro Limulus Amebosite

Lysate (LAL) method, which is applied for the control

of the existing pyrogens by using amebosite lysate,

which is obtained from Limulus Polyphemus. In this

method, endotoxins of gram negative bacteria and

amebosite lysate react under in vitro conditions. By

the results of this method, only endotoxins of gram-

negative bacteria are identified then other toxins,

which cause fever, can not be determined (Japenese

Pharmacopoeia, 2011c).

Other method is Growth Promotion Test. e

presence of microorganisms is checked in samples,

which are taken from the sterilized syringes with this

test. e samples are incubated in Soy Bean Casein

Digest Medium (SCDM) and Fluid ioglycolate

Medium (FTM) and kept throughout at least 14 days

at 30-35oC. At the end of the incubation period, media

are checked whether there is any growth of micro-

organisms or not. If there is no growth at media, it can

be concluded that the sterilization process is successful

and the syringes are sterile (Özer, 2005).

During the control of sterility, If the manufacturers

validate the sterilization process as indicated and keep

rules in the methodology of radiation dose selection,

it is possible that syringes are released without these

tests or quarantine period. ese rules are indicated in

ANSI/AAMI/ISO 11137-1994 "Sterilization of health

care products–Requirements for validation and routine

control–Radiation sterilization" by American National

Committee, that have been chosen from Association

for the Advancement of Medical Instrumentation

(AAMI) (Berk, 2002a).

For the validation of terminal sterilization method,

three processes are used (United States Pharmacopeia,

2006).

• Bioburden-based process

• Biological indicator/bioburden combined

process

• Overkill process

e bioburden-based process depends on the

33

FABAD J. Pharm. Sci., 41, 27-37, 2016

bioburden information of the product. Checking

critical control points, obtaining of the relation

between several radiation doses, bioburden counts

and radiation resistance are the crucial knowledge of

this method, especially, when the tight sterilization is

needed.

Biological indicator / bioburden combined

process shows the inactivation of microorganisms,

which are resistant to the sterilization process. Also,

this method is used when overkill process causes

possible loss at product's properties and in the EO

sterilization of syringes.

In order to benefit from overkill process product,

bioburden count and prevalence of spore forms in

the product should be known. is method can be

used when sterilizing agent and sterilization cycle

conditions don't aect the quality of product (United

States Pharmacopeia, 2006).

RADIATION EFFECTS on PLASTIC SYRINGES

Between 25-40 kGy radiation doses, some changes

can occur on the plastic syringe materials such as

decomposition, discoloration, formation of more

amorphous structure, chain scission, formation of

cross-linking bond in polymeric chains, increasing of

gas permeability. In these changes, the most important

one is the formation of radiolytic products.

ese changes are dependent on dose rate, dose

type, the type and crystallinity level of polymer, the

presence of additives and the method used (Fintzou et

al., 2007a, 2007b; Haji-Saeida et al., 2007). For example,

while cross-linking occurs in PE plastic material, PP is

sensitive to discoloration (Sastri, 2014). Also, dose rate

and the distance to the out surface cause the changes

of packaging material. e oxidative degradation in

plastic materials with e-beam is less than with gamma

radiation. Because, the exposure time to irradiation

is shorther than gamma sterilization (Fintzou et al. ,

2007a, 2007b; Haji-Saeida et al., 2007).

In order to obtain information about dierences

between non-irradiated and irradiated plastic

materials, several tests were performed as follows

(Fintzou et al., 2006):

• Mechanical testing (tensile strength,

percentage of elongation at break, compression

testing, tear strength, puncture resistance)

• Physicochemical testing (thermal testing)

• Colorimetry (the measurement of discoloration

degree)

• Fourier Transformation Infrared Spectroscopy

(FTIR) (the measurement of structural changes)

• Gas Chromatography- Mass Spectroscopy

(GC/MS) (the identification of radiolysis products)

• Electron Spin Resonance (ESR) (the

identification of radiolytic products)

• Rheological testing (the measurement of

molecular weight changes)

Fintzou et al. , (2007b) compared the eects of

e-beam and gamma rays on PP syringes. For this

purpose, they studied on non-irradiated and irradiated

at 30, 60, 120 kGy PP syringes. Gamma rays are

obtained from a source of 60Co and e-beam obtained

from a linear accelerator. Aer sterilization, they

exhibited some changes on PP syringes. Firstly, they

observed a decrease in the load at break and elongation

at break while increase in irradiation dose and also the

decrease at the gamma radiation sterilization which

was higher than e-beam sterilization. According to the

dierential scanning calorimetry test results, melting

enthalpy has decreased while irradiation dose has

increased for two methods which shows the polymers

had turned into more amorphous form due to the

eect of irradiation. Furthermore, they demonstrated

that the discoloration has been higher in the samples

which were irradiated with gamma rays and color of

these samples had turned into more yellow.

Fintzou et al. , (2007a) exhibited the eect of

e-beam on PP syringes at dierent radiation doses.

Depending on the results of mechanical tests, the

decrease was found in the load break while increase

in irradiation dose from 30 kGy to 120 kGy. In

accordance with dierential scanning calorimetry,

melting and fusion enthalpy decreased as increasing

irradiation dose. In order to understand alteration on

PP material's color, they measured color before and

aer irradiation at various doses and reported that

the color dierence increased with the increasing of

irradiation dose. In accordance with the results of FTIR

analysis, they showed that there have been formation

of aldehydes and ketones because of reaction between

oxygen molecules and free radicals. In order to define

radiolysis products which occurred at dierent

radiation doses, they applied GC-MS chromatography

and obtained some compounds such as 1,3-dichloro

2-propanone, 3,3,3-trichloro-2-methyl 1-propene, 3,4

dimethyl-phenol, 1,3 di-tert-butyl benzene, 4-tert-

butyl-2-chlorophenol at 30 kGy; outside of above

compounds 1,1,3 trichloro-2-pentanone, diisobutyl

phthalate and heptacosane at 60 and 120 kGy. Also

they indicated that at higher irradiation doses amount

of these radiolysis have been more.

Another study about gamma-irradiated

physicochemical and mechanical properties of PP

syringes was made by Fintzou et al. (2005). ey used

60Co sources for irradiation PP syringes at 30, 60 and

120 kGy doses. Aer irradiation they tested mechanical

properties of syringes, they observed that load at

break and elongation at break of syringes material

have decreased at higher irradiation doses. In order to

obtain information about the changes of melting and

crystallization behavior of PP syringes, they applied

DSC and obtained the melting temperature and fusion

enthalpy, which are connected with crystallinity, have

decreased as increasing irradiation dose. From the

results of color measurements, they also showed that

total dierences of color have increased at higher

radiation doses. According to FTIR analysis, they

observed that there have been a serious change at

1720 cm-1 in carbonyl band related to the formation of

free radicals. e radiolysis products were described

with GC-MS analysis and thirteen compounds

were identified for non-irradiated syringes, fieen

compounds for irradiated syringes at 30 kGy and

sixteen compounds for irradiated syringes at 60 and

120 kGy.

Abraham et al. (2010) made some studies for

showing the eects of e-beam radiation on physical

and chemical properties of PP syringe materials.

ey irradiated samples at 20,40,60 and 80 kGy doses

for 4 min individually. ey showed that strength,

elongation at break and viscosity had decreased with

the increase in radiation dose. Also, they indicated

melting point decreased at higher irradiation doses

depending on the results of DSC. In accordance with

ESR, they indicated that the radicals in PP syringes

had turned into another species and the short term

changes had occurred in the radicals type and

concentration in the first-two hours. In addition,

depending on the results of ESR, it was indicated that

the amount of radicals have increased during seven

days, but aer seven months any radicals have not

been found in the samples.

In the sterilization process, gamma radiation

eects on 3 types of PP syringes, which are

commercially available, were investigated. Aer

the sterilization, the properties of syringes (acidity

or alkalinity, absorbance, reducing agents, silicone

oil) have been found appropriate to the standards

as indicated in pharmacopeias. In addition, suitable

SAL doses for sterilization have been determined

and the samples, which have been prepared from

sterilized syringes with this dose, have been used

on the sterility and pyrogenicity tests. At the end of

these tests, growth and gelation have not occurred so,

these results showed that syringes could be sterilized

properly (Turker, 2009b).

In another study, eects of EO and gamma radiation

sterilization on 2 PP and 2 PE commercial syringes,

have been carried out. Sterility and gelation tests were

applied on the EO and gamma irradiation sterilized

samples, both. According to the results of these tests,

growth and gelation have not occurred. At the end of

the sterilization, syringes have been found suitable in

terms of appearance, acidity or alkalinity, absorbance,

reducing agents, silicone oil for the physicochemical

standards available in the pharmacopeias. In addition;

according to the results of mechanical tests, aer the

EO and gamma radiation sterilization maximum

strength, elastic modulus, elongation, molecular

structure have not changed in PP and PE syringes.

However, melting ow rate (MFR) values of syringes,

which are sterilized with EO, have not changed, MFR

values of 2 PP and 1 PE syringes, which are sterilized

with gamma radiation, have increased because of the

breaks in the polymer chains (Berk, 2002c).

POSSIBLE INTERACTION of SYRINGES and

CHEMICALS

Syringes are used at the administration,

transportation or storage of dierent types of solvents

and chemicals. As long as solvents and plastic syringe

materials contact with each other, the stability of

solutions can decay depending on plastic type,

solvent type, the manufacturing process. For instance

solvents may diuse to the plastic, the plastic may

extract to the solvent, undesirable products can occur.

Possible interaction between syringe materials and

solvents is very important. Because of the results of

these interactions, the integrity of plastic materials

may be lost, unwanted precipitate may occur. For

the aim of the evaluation of the chemical resistance

of plastic materials, ASTM D543 and ISO 4599 tests

are used. In accordance with these test procedures, at

least 5 samples, for each strain condition, chemicals,

materials and time, are prepared and they exposed

to the dierent solutions with suitable methods like

immersion, wipe, spray. At the end of this period,

changes in weight, possible hazing or cracks in

appearance, physical properties (such as tensile

strength and elongation) are evaluated and compared

with the control group (Sastri, 2014; Intertek Plastic

Technology Laboratories).

STABILIT Y STUDIES in the PLASTIC SYRINGES

In the literature, in order to show possible

interaction between some solvents or solutions and

plastic syringe materials some studies have been made.

Lewis et al. have investigated the possible

adsorption of atropine and ephedrine to plastic syringe

material. For this purpose, they kept atropine and

ephedrine solution in 3 plastic syringes and for control

group in 1 glass syringes during 4 days. Aerwards,

they have analyzed the samples with HPLC and have

35

FABAD J. Pharm. Sci., 41, 27-37, 2016

showed that there had been only 1.4 % reduction at

ephedrine sulfate concentration between the first

and the last day. On the other hand, they found that

the decrease in atropine sulfate concentration had

been 52 % at the end of fourth day. So according to

these results, they said that there have been possible

adsorption of atropine to plastic syringe (Lewis et al.

1994).

In order to understand the stability of heparin

sodium in plastic syringe materials, Tunbridge et

al. have diluted and stored heparin solution in PP

syringes and glass containers. According to partial

thromboplastin time (APTT) method, they found that

heparin activity had decreased considerably in glass

containers within 2 hours because of the absorption

of heparin to the glass surface. Also, they kept PP

syringes at 0-4oC and room temperature in the dark in

order to obtain information about the eect of storage

temperature. At the end of this study, they reached

that the storage time was more than three weeks and

there was an important decrease at heparin activity

(Tunbridge et al., 1981).

Stewart et al. (1992) investigated ceazidime's

stability in plastic syringes and glass vials under

dierent storage conditions. ey have kept PP plastic

syringes or glass vials containing ceazidime solutions

at dierent storage conditions. ey used HPLC for

the evaluation of ceazidime solution's concentration

and reached that ceazidime solution had been stable

in plastic syringes and glass material during 8 hour at

room temperature, 96 hour at 4oC and aer 28 and 91

days at -20oC. Also, they indicated that the number of

particulate matter is fitting to spesifications of USP for

small volume injections and the number of particulate

matter has not been changed during freezing and

thawing.

Hung et al. (1988) to check the stability of

morphine solution, they stored it at 3 and 22o C, with

and without antioxidant and preservative, in ligth and

dark in 2 types of plastic syringes at longer than 12

weeks. During the storage period, they investigated

the contaminants which is extracted to the solution

from syringe material and indicated that in 2 types

of syringes degradation of morphine have been less

than 3% in light at 22oC. Also, this value have been

found less in dark at 3oC. e results of reversed-

phase ion-pair HPLC with and without antioxidant or

preservative showed the morphine solution's shelf-life

is respectively 33 and 20 weeks in one type of plastic

syringe. In the other type of plastic syringe they found

that the shelf-life had been longer than 1 year.

Degradation of atracurium besylate injections in

plastic syringes have been investigated by Pramar et

al. ey have reached that there had been positive

eect of refrigeration on stability and also at room

temperature the atracurium besylate injections could

be stored up to 6 weeks (Pramar et al. 1996).

Nahata et al. (1992) have stored the plastic syringes

containing ceazidime (with arginine) in sterile water

at three dierent temperatures (22, 4, -20oC) at certain

time intervals. e solutions contacted with the inner

surface syringes were analyzed with HPLC to obtain

information about concentration of ceazidime, pH,

color changes and formation of any precipitate. When

the results were evaluated, the concentration has

remained the same, any precipitate has not occurred

but pH has decreased and the color of the solution has

changed from light straw to dark yellow.

Swanson et al. (2013) have studied adsorption of

99mTc-sestamibi radiopharmaceutical, which is used

common in cardiac imaging at nuclear medicine, to

6 dierent brands of plastic syringes, which are used

in hospital practice. ey indicated that the main

reason of adsorption was lubricant, used in the inside

of the syringe barrel. In addition, they showed that

the residual activity in syringes have been 22±8%

and 11±4% in barrel of syringe, 9±5% of the residual

activity have been in syringe plunger, 1% of the

residual activity in the needle and the cap of syringe

and 1% of the residual activity in the scalp vein set.

Also, any relation between volume of injection and

the residual activity could not be found.

Keskintepe et al. (2005) have studied residual

radioactivity with various 99mTc kits, which are used

in nuclear medicine, in 2 dierent commercial plastic

syringes. ey reached that the residual radioactivity

had been less in rubber ending syringe because of

little void volume. In addition, when the volume of

solution has increased 2 times, amount of radioactivity

has decreased significantly in 2 types of syringes.

In 99m Tc-Mikroagregat Albumin (99m Tc-MAA)

radiopharmaceutical used in pulmonary imaging, the

residual radioactivity have been found higher than

other kits because of the colloidal dispersion structure.

CONCLUSION

Plastic syringes, which are classified as Class IA

medical devices, are one of the most important medical

devices for the purpose of administration drugs into

the body by parenteral route. Because of widespread

use of them some requirements are designated on the

national and international basis and resulting several

standards are obligatory from quality point of view

and therefore the materials used in the production of

plastic syringes must be at medical grade.

To be sterile is one of these requirements.

Sterilization can be applied by radiation (gamma

36

Karpuz, Özer

or e-beam), EO or heat (autoclave, oven). Owing to

superiority of irradiation, this method is preferred

commonly. But, while gamma or e-beam rays use for

sterilization, possible changes in plastic material has

to be considered.

On the other hand, possible interaction between

plastic syringe materials and administered drugs with

syringe is another important issue and this interaction

is depending on the solvent type, plastic type and

manufacturing process.

As a result, hypodermic syringes which are the

most frequent used ones and made of PP or PE,

take place under the umbrella of Class IA medical

devices. ey have to own several properties indicated

in pharmacopeias, suitable process of production

indicated in standards (TS EN ISO 7886-1, TS EN

ISO 7886-2, TS EN ISO 7886-4) and pass the tests

(Mechanical test, Physicochemical test, Colorimeter,

Fourier Transformation Infrared Spectroscopy (FTIR),

Gas Chromatography/ Mass Spectroscopy (GC/MS),

Electron Spin Resonance (ESR), Rheological test)

which are applied to plastic material aer the radiation

sterilization.

REFERENCES

Abrahama, A.C., Czayka, M.A., Fisch, M.R., 2010.

Electron Beam Irradiations of Polypropylene

Syringe Barrels and the Resulting Physical and

Chemical Property Changes. Radiation Physics

and Chemistry, 79, 83–92.

Berk, F., 2002a. Tek Kullanımlık Tıbbi Malzemelerin

Gama Radyasyon ile Sterilizasyonu ve Diğer

Yöntemlerle Karşılaştırılması (Master esis).

Ankara: Hacettepe Üniversitesi, 52.

Berk, F., 2002b. Tek Kullanımlık Tıbbi Malzemelerin

Gama Radyasyon ile Sterilizasyonu ve Diğer

Yöntemlerle Karşılaştırılması (Master esis).

Ankara: Hacettepe Üniversitesi, 54.

Berk, F. 2002c. Tek Kullanımlık Tıbbi Malzemelerin

Gama Radyasyon ile Sterilizasyonu ve diğer

Yöntemlerle Karşılaştırılması (Master esis).

Ankara: Hacettepe Üniversitesi, 89-95.

Chapter 7 Syringes. http://health.prenhall.com/olsen/

pdf/Olsen_ch7.pdf (accessed 20.07.2016).

Dunne, T., Whitaker, D., 2016. Prefilled Insulin

Syringes. Anaesthesia, 71, 349-350.

European Pharmacopoeia, 2008a. Council of Europe,

Strausbourg Cedex, 379.

Fairand, B.P., 2002. Radiation Sterilization for Health

Care Products: X-Ray, Gamma, and Electron Beam.

USA: CRC Press, 5-6.

Fintzou, A.T., Badekaa, A.V., Kontominasa, M.G.,

Stahlb, M.R., Riganakosa, K.A., 2007a. Changes

in Physicochemical and Mechanical Properties of

Electron-Beam Irradiated Polypropylene Syringes

as a Function of Irradiation Dose. Radiation

Physics and Chemistry, 76, 97–107.

Fintzou, A.T., Kontominasa, M.G., Badekaa, A.V., Stahlb,

M.R., Riganakosa, K.A., 2007b. Eect of Electron-

beam and Gamma-irradiation on Physicochemical and

Mechanical Properties of Polypropylene Syringes as a

Function of Irradiation Dose: Study under Vacuum.

Radiation Physics and Chemistry, 76, 1147–1155.

Fintzou, A.T., Badeka, A.V., Kontominas, M.G.,

Riganakos, K.A.,2006. Changes in Physicochemical

and Mechanical Properties of G-irradiated

Polypropylene Syringes as a Function of Irradiation

Dose. Radiation Physics and Chemistry, 75, 87–97.

Grissinger, M., 2013. Oral Syringes: Making Better

Use of a Crucial And Economical Risk-

Reduction Strategy. Medication Errors, 38, 5-6.

Haji-Saeida, M., Sampa M.H.O., Chmielewski A.G.,

2007. Radiation Treatment for Sterilization of

Packaging Materials. Radiation Physics and

Chemistry, 76, 1535–1541.

How Products Are Made Volume 3 Syringe.

http://www.madehow.com/Volume-3/Syringe.

html#ixzz3tpvbPcEM (accessed 20.07.2016).

Hung, C.T., Young, M., Gupt, P.K., 1988. Stability

of Morphine Solutions in Plastic Syringes

Determined by Reversed-phase ion-pair Liquid

Chromatography. Journal of Pharmaceutical

Sciences, 77, 719–723.

Intertek Plastic Technology Laboratories. http://

www.ptli.com/testlopedia/tests/Compat-d543.asp

(accessed 20.07.2016).

Japenese Pharmacopoeia (JP16), 2011a. Ministry of

Health, Labour and Welfare, Tokyo, Japan 147.

Japenese Pharmacopoeia (JP16), 2011b. Ministry of

Health, Labour and Welfare, Tokyo, Japan 2221.

Japenese Pharmacopoeia (JP16), 2011c. Ministry of

Health, Labour and Welfare, Tokyo, Japan 104.

Keskintepe, D., Ozer, A.Y., 2005. Residual

Radioactivity in the Syringes used in Injection

of Radiopharmaceuticals and Factors Aecting

the Amount of Residual Radioactivity. Journal of

Pharmaceutical Sciences, 30, 176-180.

Kucklick, T., 2006. Introduction to Needles and

Cannulae In: Kucklick TR, ed. e Medical Device

R&D Handbook. Florida: CRC Press, 91-112.

37

FABAD J. Pharm. Sci., 41, 27-37, 2016

Lewis, B., Jarvi, E., Cady, P., 1994. Atropine and

Ephedrine Adsorption to Syringe Plastic. Journal

of the American Association of Nurse Anesthetists,

62, 257-60.

Ley, F.J., Winsley, B., Harbord, P., Keall, A., Summers,

T., 1972. Radiation Sterilization: Microbiological

Findings from Subprocess Dose Treatment of

Disposable Plastic Syringes. Journal of Applied

Bacteriology, 35, 53-61.

Makwana, S., Basu, B., Makasana, Y., Dharamsi,

A., 2011. Prefilled syringes: An Innovation in

Parenteral Packaging. International Journal of

Pharmaceutical Investigation, 1, 200-206.

Moraes, M.A., Weska, R.F., Beppu, M.M., 2014.

Eects of Sterilization Methods on the Physical,

Chemical and Biological Properties of Silk Fibroin

Membranes. Journal of Biomedical Materials

Research Part B, 102B, 869-876.

Nahata, M.C.,, Morosco, R.S., Fox, J.L., 1992. Stability

of Ceazidime (with arginine) Stored in Plastic

Syringes at ree Temperatures. American Journal

of Hospital Pharmacy 49, 2954-2956.

Oktay, Ş., Kayaalp, O., 2012. Genel Farmakoloji,

Farmakokinetik ve Toksikoloji. In: Oğuz Kayaalp,

ed. Akılcıl Tedavi Yönünden Tıbbi Farmakoloji.

Ankara: Ertem Basım, 27-29.

Ozer, A.Y., 2005. Gama Radyasyonla Sterilizasyon

ve Tıbbi Malzemeler. 4. Ulusal Sterilizasyon

Dezenfeksiyon Kongresi, 220-229.

Perçin, D., 2014. Sterilizasyon Uygulamaları ve

Hastane İnfeksiyonları. Antibiyotik ve Kemoterapi

Derneği Dergisi, 28, 63-66.

Pharmacology chapter 12. https://quizlet.

com/40628451/pharmacology-chapter-12-flash-

cards/ (accessed 20.07.2016).

Pramar, Y.V., Loucas, V.A, Word, D., 1996. Chemical

Stability and Adsorption of Atracurium Besylate

Injections in Disposable Plastic Syringes. Journal of

Clinical Pharmacy and erapeutics, 21, 173–175.

Sastri, V.R., 2014. Material Requirements for Plastics

used in Medical Devices. In: Sastri VR, ed. Plastics

in Medical Devices: Properties, Requirementes and

Applications. Pennsylvania: William Andrew, 33-

54.

Silindir, M., Ozer, A.Y., 2009. Sterilization Methods

and the Comparison of E-Beam Sterilization

with Gamma Radiation Sterilization. Journal of

Pharmaceutical Sciences, 34, 43–53.

Sterility Assurance Level. https://en.wikipedia.

org/wiki/Sterility_assurance_level (accessed

20.07.2016).

Stewart, J.T., Warren, F.W., Johnson, S.M., Fox, J.L.,

Mullaney, J., 1992. Stability of Ceazidime in

Plastic Syringes and Glass Vials under Various

Storage Conditions. American Journal of Hospital

Pharmacy, 49, 2765-2768.

Swanson, T.N., Troung, D.T., Paulsen, A., Hruska,

C.B., O'Connor, M.K., 2013. Adsorption of

99mTc-Sestamibi onto Plastic Syringes: Evaluation

of Factors Aecting the Degree of Adsorption

and eir Impact on Clinical Studies. Journal of

Nuclear Medicine Technology, 41, 247–252.

Syringes. http://www.syringes.cn/img/insulin-

syringes.jpg (accessed 20.07.2016).

Tunbridge, L.J., Lloyd, J.V., Penhall, R.K., Wise, A.L.,

Maloney, T., 1981. Stability of Diluted Heparin

Sodium Stored in Plastic Syringes. American

Journal of Hospital Pharmacy, 38, 1001-1004.

Türk Standardı TS EN ISO 7886-1, 1998. Şırıngalar-

Hipodermik- Bir Kullanımlık Steril Bölüm 1:

Şırıngalar-Elle Kullanım İçin. Ankara: Türk

Standartlar Enstitüsü.

Türk Standardı TS EN ISO 7886-2, 2006. Şırıngalar-

Hipodermik- Bir Kullanımlık Steril Bölüm 2:

Güç Tahrikli Şırınga Pompasıyla Kullanım İçin.

Ankara: Türk Standartlar Enstitüsü.

Türk Standardı TS EN ISO 7886-4, 2007. Şırıngalar-

Hipodermik- Bir Kullanımlık Steril Bölüm

4: Tekrar kullanımı önleme özelliğine sahip

şırıngalar. Ankara: Türk Standartlar Enstitüsü.

Turker S., 2009a. Diş Hekimliğinde (Periodontolojide)

Kullanılan Madde ve Materyallerin Gama

Radyasyonuyla Sterilizasyonu (PhD esis).

Ankara: Hacettepe Üniversitesi, 5.

Turker, S., 2009b. Diş Hekim liğinde (Perio dontolojide)

Kullanılan Madde ve Materyallerin Gama

Radyasyonuyla Sterilizasyonu (PhD esis).

Ankara: Hacettepe Üniversitesi, 168-170, 147-152.

United States Pharmacopeia–National Formulary

(USP30–NF25), 2006. Rockville MD: United

States Pharmacopeial Co., 1741.

United States Pharmacopeia–National Formulary

(USP32–NF27), 2009. Rockville MD: United

States Pharmacopeial Co., 728.

Yoshino, K., Nakamura, K., Yamashita, A., Abe, Y.,

Iwasaki, K., Kanazawa, Y., Funatsu, K., Yoshimoto,

T., Suzuki, S., 2014. Functional Evaluation and

Characterization of a Newly Developed Silicone

Oil-Free Prefillable Syringe System. Pharmaceutics,

Drug Delivery and Pharmaceutical Technolog, 103,

520–1528.

... Since the natures of such medical grade plastics are specialized due to its high heat resistance, more durable, impact strength and highly stable under UV irradiation, there may have impact on the yield of liquid fraction from thermal treatment. Likewise, these outstanding properties of medical-grade plastics contain various additives, plasticizers, slip and curing agent etc. that may influence the characteristics of the thermally cracking fuel oil 34 . Moreover, disposable medical-based plastic wastes are disposed of every day from the hospitals, clinics and the diagnostic centres, which perform as a vector of spreading of communication diseases. ...

The present work is an effort to produce liquid fuel oil from plastic based medical wastes through thermal cracking process under oxidizing conditions. The mixed plastics from medical wastes were considered as a feedstock, shredded into small pieces and heated at 773 ± 10 K for 40 min with a heating rate of 20 K/min in a batch reactor for thermal cracking process. The feedstock was characterized by proximate and ultimate analysis along with thermogravimetric investigation. Moreover, chemical compositions of the liquid fuel oil were examined by FTIR and GC–MS spectroscopy. The properties of liquid product were also examined and compared to the commercial fuel oil. The average yield of brownish and sticky liquid fuel was obtained to be 52 wt% and the gross calorific value of the liquid was found 41.32 MJ/kg which is comparable to that of commercial diesel. FTIR spectrum showed characteristic absorption bands of C–H and =CH 2 groups indicating presence of alkane and alkene compounds. GC–MS study demonstrated the chemical constituents of the liquid product that is mostly aliphatic compounds of mainly alkanes (16.28%), alkenes (10.67%), alcohols (14.65%) and ester groups (10.38%) including iso-phthalate (40.02%) as a predominant product. This experiment concludes that the liquid oil derived from thermal cracking of mixed plastics comprised of a composite mixture of organic components. A significant amount of non-degraded constituents like plasticizers, precursors, etc. remained in the product having some economic values with human health and environmental impacts during burning has been addressed in the current issue.

... In relation to the syringes, although it has not been reported in the literature on a similar study with ozone gas, this result leads to consider the ozone penetration capacity in materials made of polypropylene, even in worst case situations, such as the simulated with the syringes and their respective cap, which would hamper the access of the gas to the inside of them, similar the sterilization of products in the terminal packages by ethylene oxide process [36]. ...

Purpose: Ozone (O3) can be considered the most potent natural germicide against microorganisms (in vegetative and spore forms) with high efficiency and speed, because of its highly oxidizing activity. Despite this, there are a few studies describing the application of ozone as a sterilizing agent of medical devices. The aim of this communication was to describe the development and validation of a sterilization cycle applied to medical devices. Methods: The sterilization process was challenged using Geobacillus stearothermophilus ATCC 7953 spores, which have shown great resistance. The sterilizing effect of ozone was measured using carriers inoculated with 106 CFU/mL spores, introduced into a 3-mL syringe and lumens of tubes of different sizes and diameters simulating hospital medical products, which have undergone a half-cycle or complete cycle. Results: The results of sterilization process studied in active vegetative form of microorganisms showed that the ozone sterilization was effective with a bioburden between 105 to 107 CFU/mL with one pulse sterilizing action. The validation of the process was confirmed by the satisfactory results for the half-cycle, corresponding to a treatment with four pulses allowed sterilizing the material with bioburdens < 106 CFU/mL spores which indicate an appropriate sterility assurance level. Conclusion: The results showed that the ozone may be considered as effective and promising alternative for sterilization of thermosensitive materials and medical devices.

  • Dilek Keskintepe
  • Yekta A Ozer Yekta A Ozer

Both syringe type as well as the volume of the patient doses of radiopharmaceuticals can cause high residual activity in the syringes during application to patients. Therefore, we aimed to investigate the effects of syringe type and differences in volume and personnel on residual activity and adsorption. Injection of radiopharmaceuticals needs special attention. We concluded that less care during injection or preparation of the radiopharmaceutical in syringes will lead to a decrease in the accuracy of radioactive dose received by the patient and to an increase in environmental contamination due to the residual radioactivity in the syringes.

The functionality of a newly developed silicone oil-free (SOF) syringe system, of which the plunger stopper is coated by a novel coating technology (i-coating™), was assessed. By scanning electron microscopy observations and other analysis, it was confirmed that the plunger stopper surface was uniformly covered with the designed chemical composition. A microflow imaging analysis showed that the SOF system drastically reduced both silicone oil (SO) doplets and oil-induced aggregations in a model protein formulation, whereas a large number of subvisible particles and protein aggregations were formed when a SO system was used. Satisfactory container closure integrity (CCI) was confirmed by means of dye and microorganism penetration studies. Furthermore, no significant difference between the break loose and gliding forces was observed in the former, and stability studies revealed that the SOF system could perfectly show the aging independence in break loose force observed in the SO system. The results suggest that the introduced novel SOF system has a great potential and represents an alternative that can achieve very low subvisible particles, secure CCI, and the absence of a break loose force. In particular, no risk of SO-induced aggregation can bring additional value in the highly sensitive biotech drug market. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci

  • Vinny R. Sastri

Plastics used in medical device applications must meet stringent performance requirements through production, packaging, shipping, end use, and disposal. Many devices and device kits are sterilized before they are shipped for use. During manufacturing and during end use they also come in contact with various chemicals, solvents, bodily fluids, skin, organs, and tissues. The materials used in such devices must be resistant to the sterilization methods, chemicals, and fluids that they encounter, be compatible with bodily fluids, skin, and tissues, and still maintain their safety, effectiveness, and functionality. Requirements for plastics used in medical devices include the following: 1. Material characterization, 2. Sterilization resistance, 3. Chemical and lipid resistance, 4. Extractables and leachables characterization, 5. Biocompatibility and hemocompatiblity, and 6. Shelf life and stability. Many devices need to be packaged and sterilized either before distribution or before use. Examples of such devices are exam and surgical gloves, clean room garments, specimen cups, wound care products, sutures, needles, syringes, catheters, drain bags, IV bags, fluid delivery systems, dialysis equipment, implants, surgical instruments, dental instruments, surgery supplies, and combination products. All materials used in such medical devices, including the plastics used in them, must be capable of being sterilized without loss of performance.

Silk fibroin has been widely explored for many biomedical applications, due to its biocompatibility and biodegradability. Sterilization is a fundamental step in biomaterials processing and it must not jeopardize the functionality of medical devices. The aim of this study was to analyze the influence of different sterilization methods in the physical, chemical, and biological characteristics of dense and porous silk fibroin membranes. Silk fibroin membranes were treated by several procedures: immersion in 70% ethanol solution, ultraviolet radiation, autoclave, ethylene oxide, and gamma radiation, and were analyzed by scanning electron microscopy, Fourier-transformed infrared spectroscopy (FTIR), X-ray diffraction, tensile strength and in vitro cytotoxicity to Chinese hamster ovary cells. The results indicated that the sterilization methods did not cause perceivable morphological changes in the membranes and the membranes were not toxic to cells. The sterilization methods that used organic solvent or an increased humidity and/or temperature (70% ethanol, autoclave, and ethylene oxide) increased the silk II content in the membranes: the dense membranes became more brittle, while the porous membranes showed increased strength at break. Membranes that underwent sterilization by UV and gamma radiation presented properties similar to the nonsterilized membranes, mainly for tensile strength and FTIR results. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.

  • Tiffinee N. Swanson
  • Duong T Troung
  • Andrew Paulsen
  • Michael K O'Connor Michael K O'Connor

The purpose of this study was to document the extent of adhesion of (99m)Tc-sestamibi to syringes in patient procedures, determine factors that influence the degree of adhesion, and evaluate alternatives to our current practice that would either result in a more reproducible degree of adhesion or, ideally, eliminate adhesion. The extent of adhesion was documented in 216 patient procedures and evaluated in detail in an additional 73 patient procedures. We evaluated the nature of the adhesion and its possible causes, including the location of adhesion in injection sets, the effect of syringe type, and the effect of prerinsing of syringes with various solutions of nonradiolabeled sestamibi and (99m)Tc-sestamibi. The extent of adhesion was reevaluated in 50 procedures performed using the syringe type that demonstrated the lowest adhesion rate. The degree of adhesion of (99m)Tc-sestamibi to the injection set was found to be 20.1% ± 8.0%, with a range (10th-90th percentiles) of 9%-31%. The primary cause of adhesion appeared to be the lubricant used inside the syringe barrel. Evaluation of 6 different syringe types identified a brand with a lower adhesion rate. Reevaluation in patient procedures using this brand showed a 5.2% ± 2.5% degree of adhesion, with a range (10th-90th percentiles) of 2.5%-7.7%. Selection of the appropriate type of syringe can significantly reduce the magnitude and variability of residual (99m)Tc-sestamibi activity. With more reproducible residual activities, we have been able to achieve an approximately 20% reduction in the dispensed dose of (99m)Tc-sestamibi used in clinical procedures and a more consistent injected dose with less interpatient variation. The frequent changes in syringe design by manufacturers require that a quality control program for monitoring of residual activity be incorporated into clinical practice. This program has allowed us to maintain image quality and achieve more consistent injected patient doses in clinical procedures that use (99m)Tc-sestamibi.

Mechanical, thermal, chemical decomposition and electron spin resonance (ESR) methods were used to study electron beam irradiated polypropylene syringe barrels that were irradiated to a total fractionated dose of 0, 20, 40, 60, and 80kGy (in steps of 20kGy). Dose mapping was conducted to determine dose to and through the syringe barrel. Analysis of these data indicated that degradation of the polypropylene syringes increased with an increase in electron beam irradiation.

In the present study, the effect of electron-beam irradiation on physicochemical and mechanical properties of polypropylene (PP) syringes was studied. Three irradiation doses (30, 60 and 120kGy) were applied to all samples. Non-irradiated PP syringes were used as control samples. Electron-beam irradiation caused an increase in the degree of yellowness and in the extractable radiolysis products. A decrease in compression strength and extension at break was the result of electron-beam irradiation on mechanical properties of PP syringes. Minor differences were observed in FTIR spectra, mainly in the region of 1720cm−1, corresponding to the absorption of carbonyl compounds. Gas chromatography/mass spectrometry (GC/MS) analysis indicated the formation of a number of radiolysis compounds while a number of compounds initially present in non-irradiated syringes were destroyed by the irradiation. The degradation on polymer properties caused by electron-beam irradiation was less severe than that caused by gamma irradiation.

The effect of electron-beam and gamma irradiation under vacuum on the physicochemical and mechanical properties of commercial polypropylene (PP) syringes was studied. Irradiation doses of 30, 60 and 120 kGy were used while for comparison purposes respective non-irradiated (control) PP syringes were also studied. Mechanical tests, differential scanning calorimetry analysis, color determination and FTIR were carried out to evaluate the effect of both irradiation treatments (electron-beam and gamma irradiation) on PP syringes. Both compression strength and % extension at break decreased with increasing irradiation dose. Melting temperature as well as specific melting enthalpy also decreased while the degree of yellowness increased with increasing irradiation dose. Minor differences in FTIR spectra were observed after irradiation treatment.